CINCINNATI — P&G announced Wednesday that a new swab the company has developed will launch production for the clinical laboratory market.
The swabs, developed to help combat a still-occurring shortage in COVID-19 test components, will "reduce handling and lab processing cycle time and increase lab capacity as new home collection kits expand rapidly into the virus detection market," according to a press release from P&G.
P&G will partner with Rhinostics, a company that commercializes medical supplies, to launch the new swab.
"Rhinostics plans on registering the P&G polypropylene nasal swab as a Class I Exempt medical device and will pursue Emergency Use Authorization for home collection with rPT-PCR testing," the press release states.
P&G made no official announcement in the release that at-home test kits are a reality, but stated the new type of swab could be used in instances of at-home testing, expedite test results and become a future solution for testing for other viruses, like the flu.